BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 138274)

  • 1. [The electrophoretic-mobility-test (EMT) in the diagnosis of malignancies (author's transl)].
    Douwes FR; Hanke R; Mross K
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Dec; 87(3):281-90. PubMed ID: 138274
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macrophage electrophoretic migration test for lymphocyte sensitization to tumor antigens (author's transl)].
    Tognella S; Mantovani G; Floris C; Cengiarotti L; Del Giacco GS; Grifoni V
    Tumori; 1974; 60(3):203-10. PubMed ID: 4428498
    [No Abstract]   [Full Text] [Related]  

  • 3. [Macrophage migration inhibition test (author's transl)].
    Yamaura N
    Rinsho Byori; 1974 May; 22(5):340-7. PubMed ID: 4473068
    [No Abstract]   [Full Text] [Related]  

  • 4. The electrophoretic mobility test (EMT) and cancer diagnosis.
    Porzsolt F
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):183-7. PubMed ID: 746683
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
    Tautz C; Schneider W; Laier E; Brügmann G
    Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
    [No Abstract]   [Full Text] [Related]  

  • 7. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
    Zhao BH; Hu JK; Liang JX
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application and significance of macrophage-electrophoretic-mobility-test (MEM) in neurological diseases (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Köhler H; Günther J; Gundlach HJ
    Klin Wochenschr; 1974 May; 52(6):288-92. PubMed ID: 4408594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphocyte transformation test and migration inhibition test of macrophages in Vogt-Koyanagi-Hirada's syndrome (author's transl)].
    Yuasa T; Murai Y; Hoki T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1973 Oct; 77(10):1652-7. PubMed ID: 4799026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evidence that electrophoretic-mobility (EM) test is of no value for the diagnosis of cancer in children (author's transl)].
    Lasson U; Scherer G; Müller-Ruchholtz W
    Monatsschr Kinderheilkd; 1981 Mar; 129(3):164-7. PubMed ID: 6112683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-controlled macrophage migration inhibition test (author's transl)].
    Svejcar J; Doutlík S; Pekárek J; Hanzl M; Rybnícek A; Vacek Z
    Cas Lek Cesk; 1980; 119(11):333-7. PubMed ID: 7397721
    [No Abstract]   [Full Text] [Related]  

  • 12. [KCl-tumor extracts in the electrophoretic mobility test [EMT]. - Clinical relevance to diagnosis of gastric cancer (author's transl)].
    Muhrer KH; Schwemmle K; Stambolis C; Kahle M
    Z Gastroenterol; 1982 Jul; 20(7):376-83. PubMed ID: 7113315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The mechanism of the in vitro migration inhibition test (author's transl)].
    Sabioncello A; Dekaris D
    Lijec Vjesn; 1978 Sep; 100(9):535-42. PubMed ID: 368478
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
    Lewkonia RM; Kerr EJ; Irvine WJ
    Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The macrophage electrophoretic mobility LAD test--a diagnostic method for multiple sclerosis (author's transl)].
    Meyer-Rienecker H; Jenessen HL; Köhler H; Günther JK
    J Neurol; 1976 Feb; 211(3):229-40. PubMed ID: 55489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Lancet; 1972 Sep; 2(7778):627-9. PubMed ID: 4116778
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophage electrophoretic mobility test for brain tumors and malignancies.
    Yongde S; Zhensheng T; Chuanshen L; Baoguo X; Zijun L; Yifei S; Yanfang J; Xindi Y; Meizhen L; Xuezhen S
    Chin Med J (Engl); 1979 Mar; 92(3):211-5. PubMed ID: 109261
    [No Abstract]   [Full Text] [Related]  

  • 20. [On a cellular sensitización to sperm antigens, measured through the macrophages migration inhibition (author's transl)].
    Mettler L; Mesek-Selchow B
    Reproduccion; 1974; 1(1):89-95. PubMed ID: 4478079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.